SavedAdd your journal

Journals / Journal of Health Sciences and Medicine / 2026 / Volume: 8 Issue: 2

Evaluation of hematologic inflammation parameters and cranial magnetic resonance imaging findings in patients with trigeminal neuralgia

Trigeminal nevraljili hastalarda hematolojik inflamasyon parametrelerinin ve kranial manyetik rezonans görüntüleme bulgularının değerlendirilmesi

Demet Aygün(İSTANBUL ATLAS ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-1828-1811
Hüseyin Doğu(İstanbul Atlas Üniversitesi)0000-0002-7754-4984
Pages
—
Publication Date
2025-03-21
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These markers may serve as useful non-invasive tools for predicting TN and related MRI findings.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: This study aimed to evaluate the relationship between trigeminal neuralgia (TN) and hematological parameters, including leukocyte-based inflammatory indices, and to explore their association with cranial magnetic resonance imaging (MRI) findings.
📊
Key Findings & Data:Methods: A retrospective analysis was conducted on 114 patients with newly diagnosed TN and 114 healthy control groups with comparable demographic characteristics.
💡
Conclusion & Impact:These markers may serve as useful non-invasive tools for predicting TN and related MRI findings.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Trigeminal neuralgia · inflammation markers · white matter lesions

Abstract

Aims: This study aimed to evaluate the relationship between trigeminal neuralgia (TN) and hematological parameters, including leukocyte-based inflammatory indices, and to explore their association with cranial magnetic resonance imaging (MRI) findings. Methods: A retrospective analysis was conducted on 114 patients with newly diagnosed TN and 114 healthy control groups with comparable demographic characteristics. Clinical, laboratory, and cranial MRI data were collected from hospital records. White matter abnormalities were identified via cranial MRI, and inflammatory indices were calculated as follows: neutrophil-to-lymphocyte ratio (NLR)=Neutrophil count/lymphocyte count, platelet-to-lymphocyte ratio (PLR)=Platelet count/lymphocyte count, Systemic Immune-Inflammation Index (SII)=Platelet count×neutrophil count/lymphocyte count, and Systemic Inflammatory Response Index (SIRI)=Neutrophil count×monocyte count/lymphocyte count. Results: TN patients showed significantly higher leukocyte counts (7.4±1.8 vs. 6.0±1.9 ×10³/μl, p<0.001), neutrophil counts (4.2±1.1 vs. 2.8±0.8×10³/μl, p<0.001), CRP levels (median: 2.6 vs. 0.8 mg/dl, p<0.001), and inflammatory indices (NLR, PLR, SII, and SIRI; p<0.001 for all) compared to control group. White matter abnormalities were detected in 16.7% of TN patients, predominantly in the frontal (11.4%) and parieto-occipital (7.0%) regions. Patients with white matter abnormalities exhibited significantly higher inflammatory indices than those without. Compared to other inflammatory parameters, SIRI demonstrated the highest diagnostic performance for TN (threshold: 0.7; sensitivity: 84.2%, specificity: 82.5%) and white matter abnormalities (threshold: 1.3; sensitivity: 78.9%, specificity: 82.1%). Conclusion: Inflammatory markers, particularly SIRI, are significantly elevated in TN patients and are associated with white matter abnormalities. These markers may serve as useful non-invasive tools for predicting TN and related MRI findings.

Özet

Amaç: Bu çalışmanın amacı, trigeminal nevralji (TN) ile lökosit bazlı inflamatuar indeksler de dahil olmak üzere hematolojik parametreler arasındaki ilişkiyi değerlendirmek ve bunların kranial manyetik rezonans görüntüleme (MRI) bulgularıyla ilişkisini araştırmaktır. Yöntemler: Yeni tanı almış TN'li 114 hasta ve benzer demografik özelliklere sahip 114 sağlıklı kontrol grubu üzerinde retrospektif bir analiz yürütüldü. Klinik, laboratuvar ve kranial MRI verileri hastane kayıtlarından toplandı. Kranial MRI ile beyaz cevher anormallikleri belirlendi ve inflamatuar indeksler şu şekilde hesaplandı: nötrofil-lenfosit oranı (NLR) = nötrofil sayısı / lenfosit sayısı, trombosit-lenfosit oranı (PLR = trombosit sayısı / lenfosit sayısı, sistemik immün-inflamasyon indeksi (SII) = trombosit sayısı × nötrofil sayısı / lenfosit sayısı ve sistemik inflamatuar yanıt indeksi (SIRI) = nötrofil sayısı × monosit sayısı / lenfosit sayısı. Sonuçlar: TN hastalarında önemli ölçüde daha yüksek lökosit sayısı (7,4 ± 1,8 - 6,0 ± 1,9 ×10³/μL, p < 0,001), nötrofil sayısı (4,2 ± 1,1 - 2,8 ± 0,8 ×10³/μL, p < 0,001) görüldü. CRP düzeyleri (ortanca: 2,6 - 0,8 mg/dL, p < 0,001) ve inflamasyon indeksleri (NLR, PLR, SII ve SIRI; hepsi için p < 0,001) kontrol grubuyla karşılaştırıldı. Beyaz cevher anormallikleri TN hastalarının %16,7'sinde, ağırlıklı olarak frontal (%11,4) ve parieto-oksipital (%7,0) bölgelerde tespit edildi. Beyaz cevher anormallikleri olan hastalar, olmayanlara göre önemli ölçüde daha yüksek inflamasyon indeksleri sergiledi. Diğer inflamasyon parametreleriyle karşılaştırıldığında, SIRI TN (eşik: 0,7; duyarlılık: %84,2, özgüllük: %82,5) ve beyaz cevher anormallikleri (eşik: 1,3; duyarlılık: %78,9, özgüllük: %82,1) için en yüksek tanı performansını gösterdi. Sonuç: İnflamasyon belirteçleri, özellikle SIRI, TN hastalarında önemli ölçüde yüksektir ve beyaz cevher anormallikleri ile ilişkilidir. Bu belirteçler, TN ve ilgili MRI bulgularını tahmin etmede yararlı non-invaziv araçlar olarak hizmet edebilir.

🔖

Cite This Article

Aygün, D., Doğu, H. (2025). Evaluation of hematologic inflammation parameters and cranial magnetic resonance imaging findings in patients with trigeminal neuralgia. Journal of Health Sciences and Medicine, Volume: 8 Issue: 2. https://doi.org/10.32322/jhsm.1556900

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (39)

  1. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. doi:10.1177/0333102417738202
  2. Montano N, Conforti G, Di Bonaventura R, Meglio M, Fernandez E, Papacci F. Advances in diagnosis and treatment of trigeminal neuralgia. Ther Clin Risk Manag. 2015;11:289-299. doi:10.2147/TCRM.S37592
  3. Jones MR, Urits I, Ehrhardt KP, et al. A comprehensive review of trigeminal neuralgia. Curr Pain Headache Rep. 2019;23(10):74. doi:10. 1007/s11916-019-0810-0
  4. Chen Q, Yi DI, Perez JNJ, et al. The molecular basis and pathophysiology of trigeminal neuralgia. Int J Mol Sci. 2022;23(7):3604. doi:10.3390/ijms 23073604
  5. Peker S, Kurtkaya O, Uzun I, Pamir MN. Microanatomy of the central myelin-peripheral myelin transition zone of the trigeminal nerve. Neurosurgery. 2006;59(2):354-359. doi:10.1227/01.NEU.0000223501.27220.69
  6. Love S, Hilton DA, Coakham HB. Central demyelination of the 5th nerve root in trigeminal neuralgia associated with vascular compression. Brain Pathol. 1998;8(1):1-11. doi:10.1111/j.1750-3639.1998.tb00126.x
  7. Wang J, Ou SW, Wang YJ. Distribution and function of voltage-gated sodium channels in the nervous system. Channels (Austin). 2017;11(6): 534-554. doi:10.1080/19336950.2017.1380758
  8. Laedermann CJ, Abriel H, Decosterd I. Post-translational modifications of voltage-gated sodium channels in chronic pain syndromes. Front Pharmacol. 2015;6:263. doi:10.3389/fphar.2015.00263
  9. Levinson SR, Luo S, Henry MA. The role of sodium channels in chronic pain. Muscle Nerve. 2012;46(2):155-165. doi:10.1002/mus.23314
  10. Ostertag C, Friedman TN, Keough MB, Kerr BJ, Sankar T. Heightened presence of inflammatory mediators in the cerebrospinal fluid of patients with trigeminal neuralgia. Pain Rep. 2023;8(6):e1117. doi:10.1097/PR9. 0000000000001117
  11. Ericson H, Abu Hamdeh S, Freyhult E, et al. Cerebrospinal fluid biomarkers of inflammation in trigeminal neuralgia patients operated with microvascular decompression. Pain. 2019;160(11):2603-2611. doi:10.1097/j.pain.0000000000001649
  12. Wang Y, Cao DY, Remeniuk B, Krimmel S, Seminowicz DA, Zhang M. Altered brain structure and function associated with sensory and affective components of classic trigeminal neuralgia. Pain. 2017;158(8): 1561-1570. doi:10.1097/j.pain.0000000000000951
  13. Obermann M, Rodriguez-Raecke R, Naegel S, et al. Gray matter volume reduction reflects chronic pain in trigeminal neuralgia. Neuroimage. 2013;74:352-358. doi:10.1016/j.neuroimage.2013.02.029
  14. Yao Y, Chang B, Li S. Relationship of inflammation with trigeminal neuralgia. J Craniofac Surg. 2020;31(2):e110-e113. doi:10.1097/SCS.0000 000000005879
  15. Altunisik E, Tak AZA. Comparison of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients diagnosed with trigeminal neuralgia and healthy controls. Ann Med Res. 2021;28(4):704-708. doi: 10.5455/annalsmedres.2020.05.437
  16. Tuncer Z, Akbulut N, Ekmekçi UC, Çirkinoğlu GG, Öztürk V, Erkin Y. Monocyte to high-density lipoprotein ratio and neutrophil to lymphocyte ratio in trigeminal neuralgia patients: a retrospective cohort study: MHR and NLR in trigeminal neuralgia. J Surg Med. 2023; 7(9):568-573. doi.org/10.28982/josam.7884
  17. Wahlund LO, Barkhof F, Fazekas F, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001; 32(6):1318-22. doi:10.1161/01.str.32.6.1318
  18. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837-845. doi.org/10. 2307/2531595
  19. Demartini C, Greco R, Zanaboni AM, et al. Antagonism of transient receptor potential ankyrin type-1 channels as a potential target for the treatment of trigeminal neuropathic pain: study in an animal model. Int J Mol Sci. 2018;19(11):3320. doi:10.3390/ijms19113320
  20. Lu ZY, Fan J, Yu LH, Ma B, Cheng LM. The up-regulation of TNF-alpha maintains trigeminal neuralgia by modulating MAPKs phosphorylation and BKCa channels in trigeminal nucleus caudalis. Front Cell Neurosci. 2021;15:764141. doi:10.3389/fncel.2021.764141
  21. Zhang ZJ, Dong YL, Lu Y, Cao S, Zhao ZQ, Gao YJ. Chemokine CCL2 and its receptor CCR2 in the medullary dorsal horn are involved in trigeminal neuropathic pain. J Neuroinflammation. 2012;9:136. doi:10. 1186/1742-2094-9-136
  22. Liu MX, Zhong J, Xia L, Dou NN, Li ST. A correlative analysis between inflammatory cytokines and trigeminal neuralgia or hemifacial spasm. Neurol Res. 2019;41(4):335-340. doi:10.1080/01616412.2018.1564188
  23. Trevisan G, Benemei S, Materazzi S, et al. TRPA1 mediates trigeminal neuropathic pain in mice downstream of monocytes/macrophages and oxidative stress. Brain. 2016;139(Pt 5):1361-1377. doi:10.1093/brain/aww038
  24. Tecchio C, Micheletti A, Cassatella MA. Neutrophil-derived cytokines: facts beyond expression. Front Immunol. 2014;5:508. doi:10.3389/fimmu.2014.00508
  25. Algul FE, Unver FB. Relationship between trigeminal neuralgia and the C-reactive protein/albumin ratio. Turk J Neurol. 2024;30(3):134-140. doi:10.55697/tnd.2024.134
  26. Lai S, Li H, Xing Y, Wu D, Wang L, Liang Q. Exploring the role of inflammatory biomarkers in trigeminal neuralgia. Brain Behav Immun Health. 2024;43:100930. doi:10.1016/j.bbih.2024.100930
  27. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2): 119-177. doi:10.1093/eurheartj/ehx393
  28. Chen F, Chao M, Huang T, et al. The role of preoperative inflammatory markers in patients with central nervous system tumors, focus on glioma. Front Oncol. 2022;12:1055783. doi:10.3389/fonc.2022.1055783
  29. Liu Y, Tanaka E. Pathogenesis, diagnosis, and management of trigeminal neuralgia: a narrative review. J Clin Med. 2025;14(2):528. doi:10.3390/jcm14020528
  30. Lee GW, Son JY, Lee AR, Ju JS, Bae YC, Ahn DK. Central VEGF-A pathway plays a key role in the development of trigeminal neuropathic pain in rats. Mol Pain. 2019;15:1744806919872602. doi:10.1177/1744806919872602
  31. Patil S, Testarelli L. Assessment of growth factors, cytokines, and cellular markers in saliva of patients with trigeminal neuralgia. Molecules. 2021;26(10):2964. doi:10.3390/molecules26102964
  32. Liu Y, Li J, Butzkueven H, et al. Microstructural abnormalities in the trigeminal nerves of patients with trigeminal neuralgia revealed by multiple diffusion metrics. Eur J Radiol. 2013;82(5):783-786. doi:10.1016/ j.ejrad.2012.11.027
  33. Wang Y, Li D, Bao F, Guo C, Ma S, Zhang M. Microstructural abnormalities of the trigeminal nerve correlate with pain severity and concomitant emotional dysfunctions in idiopathic trigeminal neuralgia: a randomized, prospective, double-blind study. Magn Reson Imag. 2016;34(5):609-616. doi:10.1016/j.mri.2015.11.013
  34. DeSouza DD, Hodaie M, Davis KD. Abnormal trigeminal nerve microstructure and brain white matter in idiopathic trigeminal neuralgia. Pain. 2014;155(1):37-44. doi:10.1016/j.pain.2013.08.029
  35. Wu M, Jiang X, Qiu J, Fu X, Niu C. Gray and white matter abnormalities in primary trigeminal neuralgia with and without neurovascular compression. J Headache Pain. 2020;21(1):136. doi:10.1186/s10194-020-01205-3
  36. Moayedi M, Hodaie M. Trigeminal nerve and white matter brain abnormalities in chronic orofacial pain disorders. Pain Rep. 2019;4(4): e755. doi:10.1097/PR9.0000000000000755
  37. Liu J, Zhu J, Yuan F, Zhang X, Zhang Q. Abnormal brain white matter in patients with right trigeminal neuralgia: a diffusion tensor imaging study. J Headache Pain. 2018;19(1):46. doi:10.1186/s10194-018-0871-1
  38. Chiang PL, Chen HL, Lu CH, et al. White matter damage and systemic inflammation in Parkinson’s disease. BMC Neurosci. 2017;18(1):48. doi: 10.1186/s12868-017-0367-y
  39. Miklossy J, Doudet DD, Schwab C, Yu S, McGeer EG, McGeer PL. Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys. Exp Neurol. 2006;197(2):275-283. doi:10.1016/j.expneurol. 2005.10.034